filgotinib

Alfasigma SpA’s €170m Deal Expands Filgotinib Business

📅 On January 2nd, 2024, Alfasigma SpA 💪 signed a €170m deal with Galapagos NV to expand their pipeline and market presence 🌍. Additionally, former Galapagos CCO, Michele Manto, joins Alfasigma as CCO Western Europe. 💼